Swaypay
1 known investors
Disclosure Facts is a fintech payment method for regulated health endorsement deals that produces an evidentiary compliance record.
Also known as Disclosure Facts
Investors · 1
Company profile
researched Aug 2026Swaypay, operating publicly as Disclosure Facts, is a fintech company that positions itself as a payment method for regulated endorsement transactions in healthcare and pharmaceutical marketing. The product sits around the commercial transaction between an advertiser (for example pharma, DTC telehealth, weight loss, mental health, diagnostics or wearable device brands) and an endorser (clinicians, patients, caregivers or key opinion leaders), rather than around the creative content itself. Both sides open a transaction, clear compliance checkpoints such as verified clinician licensure, eligibility verification, disclosure of material connection and documented supervision, and sign attestations; payment is then released to the endorser and the company issues a primary source record of the deal.
Each completed transaction generates an evidentiary package intended for later scrutiny, including a disclosure record, an MLR review packet, an Open Payments report and an FDA promotional review submission packet. The company states these records are designed to meet evidentiary standards under Federal Rules of Evidence 803(6) and 902(11), while noting admissibility in any given proceeding is not guaranteed. Contexts cited for use of the records include FTC civil investigative demands, FDA warning letters, state attorney general advertising inquiries, NCQA compliance audits, NAD challenges, litigation discovery, investor due diligence and social platform appeals.
The company describes itself as a fintech rather than a licensed escrow service. Escrow functions are provided through Escrow.com, with buyer funds held in trust and disbursed to sellers by Internet Escrow Services Inc., a licensed Escrow.com subsidiary regulated under California Escrow Law by the Department of Financial Protection and Innovation; Disclosure Facts states it does not hold, transmit or disburse funds itself, and that conditions it sets must be met before seller funds are released.
Founding story
Founder Kaeya Majmundar spent the first five years building the company inside what the company describes as a $435M venture-backed stress test of regulated endorsement transactions, spanning 11 startups — including one that grew from zero to $1.1B in four years before shutting down 16 months later.
Business model
The company inserts itself into endorsement deals as a payment method, integrating via a "Disclosure Facts payment button" that can be attached to any endorsement transaction. Funds move through a third-party licensed escrow provider (Escrow.com / Internet Escrow Services Inc.), with release conditioned on both buyer and seller completing compliance checkpoints. The company's own deliverable is the verification workflow and the resulting evidentiary record rather than the creative work or the custody of money.
Traction
The company states it has managed more than 1,300 endorsement transactions end to end, from first touch through dispute resolution.
▸Full profile — market position, technology, go-to-market, geography, risks & controversies
Market position
Positions itself as building the default payment method for regulated endorsements, an area it describes as previously uninsurable risk, and claims to work behind fast-growing telehealth brands. It is backed by the Validation Institute, valid through January 2027, including a $100,000 Credibility Guarantee and a Validation Report.
The company frames its offering as distinct from conventional escrow: escrow protects the money, while its service is intended to protect the deal for both parties before, during and after payment, by producing an independent, primary-source evidentiary record. It also contrasts its approach with reliance on brand-side legal teams, which it characterizes as protecting the brand rather than the endorser and as introducing weeks of per-deal back-and-forth. It states it does not touch the creative, only the surrounding transaction.
Technology
A transaction workflow that standardizes and timestamps each step of an endorsement deal: identity and clinician licensure verification, eligibility verification, signed attestations, disclosure issuance, brand approval and publication of the record. Outputs are structured compliance artifacts — a disclosure record, MLR review packet, Open Payments report and FDA promotional review submission packet — designed against Federal Rules of Evidence 803(6) and 902(11) business-records and certification standards.
Go-to-market
Self-serve web intake in which a prospective buyer, seller or broker specifies transaction parameters (party type, endorsement type, country, channel, brand category and deal size) and books a demo. Marketing emphasizes regulatory exposure, including a stated $43,792 FTC fine per non-compliant influencer post, and the company promotes a compliance "founder hotline." It states it works alongside insurers, healthcare accreditors, advertising lawyers and regulators.
Buyers, sellers and brokers of health endorsements, including clinicians, patients, caregivers and KOLs/experts on the seller side, and advertisers in pharma, DTC telehealth, women's health, men's health, diagnostics, wearable devices, mental health, weight loss and general health on the buyer side. Deals are handled directly or via agencies, platforms or other intermediaries, across transaction sizes described from roughly $100 to $10M. The site references categories such as GLP-1, ED, ADHD, HRT and PrEP telehealth brands.
Geography
Listed address is 1642 R Street NW, Washington, DC 20009. The intake flow covers endorsements originating in the USA, Canada, UK, Australia and the EU, with compliance framing oriented to US regulators (FTC, FDA, state attorneys general, Open Payments).
Risks & controversies
The company notes it is a fintech and not a licensed escrow service, and does not hold, transmit or disburse funds. It discloses that records it produces are designed to meet Federal Rules of Evidence standards but that admissibility in any specific proceeding is not guaranteed. Marketing figures it cites — including $1.1B+ in damages sought across five influencer disclosure class actions filed in H1 2025 (Celsius, Shein, Alo Yoga, Revolve, Beach Bunny) — are described as damages sought rather than awarded, with motions to dismiss pending.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
▸Research sources · 1
primary sources listed
- Swaypayswaypayit.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Swaypay do?
- Disclosure Facts is a fintech payment method for regulated health endorsement deals that produces an evidentiary compliance record.
- Who are Swaypay's investors?
- Swaypay's investors include Flucas Ventures.